1McMaster University, Hamilton, Ontario, Canada
2Department of Surgery, University of Western Ontario, London, Ontario, Canada
3Orthopaedic Department UGHL, School of Health Sciences, University of Thessalia, Larissa, Greece
4Sancheti Institute of Orthopaedics and Rehabilitation, Pune, India
5Joint Research, OLVG, Amsterdam, the Netherlands
6Sanofi Genzyme, Bridgewater, New Jersey
7Amgen, Inc., Thousand Oaks, California
8Department of Orthopaedic Surgery, University of California, San Francisco, San Francisco, California
9Orthopaedic Trauma Institute, Zuckerberg San Francisco General Hospital, San Francisco, California
aEmail address for M. Bhandari: [email protected]
Disclosure: This study was sponsored by Amgen, Inc. and UCB Pharma. Four authors (N.D., R.E.D.-A., O.E., and A.C.) are employees of Amgen, Inc., the manufacturer of the drug used in the study, and one author (J.C.) was a previous employee of UCB Pharma. On the Disclosure of Potential Conflicts of Interest forms, which are provided with the online version of the article, one or more of the authors checked “yes” to indicate that the author had a relevant financial relationship in the biomedical arena outside the submitted work (including relationships with Amgen, Inc.) (https://links.lww.com/JBJS/F872).
